In contrast, in a model of HER2-positive BC, cells activated with EGF strongly overexpressed DUSP6, while HER2 expression downregulated by a stable intracellular expression of an anti-HER2 antibody resulted in DUSP6 downregulation. This evidence concerns the gene EGF and breast cancer.